RheumaGen Revenue and Competitors

Denver, CO USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • RheumaGen's estimated annual revenue is currently $1.1M per year.(i)
  • RheumaGen's estimated revenue per employee is $155,000

Employee Data

  • RheumaGen has 7 Employees.(i)
  • RheumaGen grew their employee count by 17% last year.

RheumaGen's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Co-Founder & Chief Operating OfficerReveal Email/Phone
3
VP, FinanceReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M35483%$25MN/A
#2
$2M1318%N/AN/A
#3
$3.4M2210%N/AN/A
#4
$68M439-3%N/AN/A
#5
$2M1330%N/AN/A
#6
$4M268%N/AN/A
#7
$2.7M35-10%$23.2MN/A
#8
$5.3M3470%N/AN/A
#9
$1.7M11-8%N/AN/A
#10
$3.1M20-17%N/AN/A
Add Company

What Is RheumaGen?

RheumaGen is a private biotechnology company engineering a new class of therapeutics to cure major autoimmune diseases at their source. RheumaGen focuses on editing the human leukocyte antigen (HLA), or “immune gene,” to develop one-time, curative cell and gene therapies. RheumaGen is headquartered in Aurora, Colorado. For more information, please visit rheumagen.com. \n \n\n \n \n Show more\n \n\n \n\n\n \n \n Show less

keywords:N/A

N/A

Total Funding

7

Number of Employees

$1.1M

Revenue (est)

17%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.1M7N/AN/A
#2
$0.5M7N/AN/A
#3
$0.5M7N/AN/A
#4
$0.5M70%N/A
#5
$0.5M7-46%N/A